课题基金 / 基金详情

SIALYLATED SURFACE ANTIGENS OF CAMPYLOBACTER SPP

SIALYLATED SURFACE ANTIGENS OF CAMPYLOBACTER SPP
弯曲杆菌的唾液酸化表面抗原
批准号:
2902171
负责人:
Patricia Guerry
金额:
$17.68万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2002-06-30

项目摘要

项目成果

Patricia Guerry的其他基金

相关文献

中文摘要
翻译
描述(改编自申请人的摘要):Guerry及其同事,在 对新R 01申请的第一次修正,建议研究 大肠弯曲杆菌(Campylobacter coli)和C.空肠基因负责翻译后 鞭毛蛋白的糖基化。他们提出,改性的表面暴露 蛋白质在菌株的血清特异性中起作用, 抗原,可能用于疫苗开发。其办法将包括 参与唾液酸生物合成的基因的分子遗传学分析, 将这些残留物添加到鞭毛蛋白中。体外侵袭测定和动物实验 (雪貂和兔)感染模型将用于评估C. coli和C.空肠糖基化缺陷突变体。有三个具体的 目标。1.完成翻译后修饰的表征 鞭毛蛋白基因在C. coliVC 167,并将遗传学与 翻译后修饰的结构; 2.特征化和变异 唾液酸生物合成基因在两株C.空肠,MSC 57360和 81-176; 3.测定VC 167突变体的毒力和免疫原性, MSC和81-176,它们在翻译后修饰基因中有缺陷 和/或具有非唾液酸化的LPS。
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Guerry and colleagues, in a first amendment to a new R01 application, propose to study the genetics of Campylobacter coli and C. jejuni genes responsible for post-translational glycosylation of flagellin. They propose that the modified surface-exposed protein plays a role in serospecificity of strains and serves as important antigens, potentially useful for vaccine development. The approach will include molecular genetic analysis of genes involved in sialic acid biosynthesis and addition of these residues to flagellin. In vitro invasion assays and animal (ferret and rabbit) models of infection will be used to assess virulence of C. coli and C. jejuni glycosylation-deficient mutants. There are three specific aims. 1. Complete the characterization of the post-translational modification genes of flagellin in C. coli VC167, and correlate the genetics with the structure of the post-translational modification; 2. Characterize and mutate sialic acid biosynthetic genes in two strains of C. jejuni, MSC57360 and 81-176; and 3. Measure the virulence and immunogenicity of mutants of VC167, MSC, and 81-176 which are defective in post-translational modification genes and/or have non-sialylated LPS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Capsule conjugate vaccines against ETEC and Campylobacter
Capsule conjugate vaccines against ETEC and Campylobacter
Capsule conjugate vaccines against ETEC and Campylobacter
Capsule conjugate vaccines against ETEC and Campylobacter